Hot Features
Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.
Pyxis Oncology Inc is a preclinical oncology company focused on developing an arsenal of next-generation therapeutics to target difficult-to-treat cancers and improve quality of life for patients. It develops the product candidates with the objective to directly kill tumor cells, and to address the ... Pyxis Oncology Inc is a preclinical oncology company focused on developing an arsenal of next-generation therapeutics to target difficult-to-treat cancers and improve quality of life for patients. It develops the product candidates with the objective to directly kill tumor cells, and to address the underlying pathologies created by cancer that enable its uncontrollable proliferation and immune evasion. Show more
— PYX-201 achieved a confirmed 50% ORR by RECIST 1.1 including one Complete Response and 100% Disease Control Rate in six heavily pretreated HNSCC patients, supporting differentiated mono and...
- Preliminary data from the first-in-patient Phase 1 dose escalation trial of PYX-201 to be announced at upcoming virtual and in-person event in New York City on Wednesday, November 20, 2024, at...
BOSTON, Nov. 11, 2024 (GLOBE NEWSWIRE) -- Pyxis Oncology, Inc. (Nasdaq: PYXS), a clinical stage company focused on developing next generation therapeutics to target difficult-to-treat cancers...
BOSTON, Aug. 29, 2024 (GLOBE NEWSWIRE) -- Pyxis Oncology, Inc. (Nasdaq: PYXS), a clinical stage company focused on developing next generation therapeutics to target difficult-to-treat cancers...
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -0.44 | -10.3286384977 | 4.26 | 4.45 | 3.8 | 1601164 | 3.95022876 | CS |
| 4 | 0.22 | 6.11111111111 | 3.6 | 5.3899 | 3.56 | 844675 | 4.05618758 | CS |
| 12 | 0.14 | 3.80434782609 | 3.68 | 5.3899 | 3 | 634462 | 3.79437885 | CS |
| 26 | -0.33 | -7.95180722892 | 4.15 | 5.3899 | 2.81 | 597755 | 3.60709072 | CS |
| 52 | 2.38 | 165.277777778 | 1.44 | 6.85 | 1.35 | 599255 | 4.03095753 | CS |
| 156 | -8.78 | -69.6825396825 | 12.6 | 13.3 | 1.1 | 604241 | 3.9748532 | CS |
| 260 | -15.18 | -79.8947368421 | 19 | 19 | 1.1 | 592724 | 4.15328455 | CS |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
Premium
